DNA Extraction from Blood Spots: Dried Blood Spot Protocol

Dried blood spot (DBS) DNA extraction is a method for isolating genomic or pathogen DNA from whole blood that has been collected onto absorbent filter paper and allowed to dry. This technique is particularly useful when venipuncture is impractical, when samples must be stored or transported without refrigeration, or when archived neonatal screening cards (Guthrie cards) are the only available specimen. The method involves punching a small disc from the dried blood spot, lysing the cells to release DNA, and purifying the nucleic acid for downstream applications such as PCR, genotyping, or sequencing. DBS DNA extraction enables retrospective molecular studies, remote or self-collected sampling, and large-scale epidemiological surveys where conventional blood collection is logistically challenging.

At a Glance

Scientific Principle

Dried blood spot DNA extraction relies on the physical and chemical release of nucleic acids from blood cells immobilized on a solid support. When whole blood is applied to filter paper, the cellular components—including erythrocytes, leukocytes, and platelets—become trapped within the paper fibers as the liquid evaporates. The drying process itself does not degrade DNA significantly; rather, it preserves nucleic acids by removing water required for nuclease activity and microbial growth.

The extraction workflow exploits three fundamental processes:

1. Cell lysis: A detergent-based lysis buffer (typically containing sodium dodecyl sulfate or sarkosyl) disrupts cellular and nuclear membranes, releasing DNA into solution. Proteinase K is commonly added to digest histones and other DNA-binding proteins, improving DNA accessibility and reducing protein contamination.

2. DNA purification: Released DNA is separated from cellular debris, proteins, and inhibitors using either solid-phase (silica membrane or magnetic bead) binding or organic extraction (phenol-chloroform). Solid-phase methods are preferred for their speed, reproducibility, and compatibility with automation.

3. Elution: Purified DNA is recovered in a low-ionic-strength buffer (e.g., TE or nuclease-free water) and is ready for downstream applications.

The key challenge unique to DBS samples is the presence of PCR inhibitors that co-purify with DNA from the paper matrix. Heme, porphyrins, and other blood components can inhibit Taq polymerase, necessitating thorough washing steps or the use of inhibitor-tolerant polymerases [1][2].

Materials and Instrumentation Choices

Collection Devices

The choice of collection device significantly impacts DNA yield and quality. Two broad categories exist:

• Cellulosic paper: Whatman 903 Protein Saver Cards and similar cellulose-based papers are the traditional standard for newborn screening and have been used extensively in retrospective viral DNA detection studies [1]. They are inexpensive and widely available but can retain heme inhibitors.

• Polymeric devices: Tasso-M20 (TASSO Inc.) and Mitra (Neoteryx) devices use polymer-based absorptive tips that collect a fixed blood volume (typically 10–20 µL). These devices show improved DNA recovery and reduced inhibitor carryover compared to cellulosic paper, particularly for gene doping detection applications [3].

For most research applications, cellulosic paper is adequate. Polymeric devices are recommended when maximum sensitivity is required for low-copy-number targets or when quantitative accuracy is critical.

Punching Tools

• Manual hole punch: A 3–6 mm diameter punch is standard. Clean the punch between samples with 70% ethanol to prevent cross-contamination.
• Automated punchers: PerkinElmer 1296-071 or similar systems enable high-throughput processing with barcode tracking.

Lysis and Digestion Reagents

• Lysis buffer: 10 mM Tris-HCl (pH 8.0), 0.5% SDS, 5 mM EDTA, 200 mM NaCl. Some protocols add 0.1% Tween-20 or Triton X-100.
• Proteinase K: 20 mg/mL stock; use at 0.5–1 mg/mL final concentration.
• Dithiothreitol (DTT): 1 mM final concentration can improve lysis of dried cells.

Purification Systems

• Silica membrane columns: Qiagen DNeasy Blood & Tissue Kit, QIAamp DNA Mini Kit, or equivalent. These provide high-purity DNA suitable for most downstream applications.
• Magnetic beads: AMPure XP or similar beads enable automation and reduce hands-on time.
• Organic extraction: Phenol-chloroform-isoamyl alcohol (25:24:1) followed by ethanol precipitation. This method yields high-molecular-weight DNA but is more labor-intensive and uses hazardous chemicals.

Equipment

• Microcentrifuge (≥14,000 × g)
• Heating block or water bath (56°C for proteinase K digestion; 70°C for elution)
• Vortex mixer
• Pipettes with aerosol-barrier tips
• UV-Vis spectrophotometer (NanoDrop or equivalent) or fluorometer (Qubit) for quantification

Controls

Proper controls are essential for DBS DNA extraction to distinguish true results from contamination or inhibition artifacts.

For retrospective studies using Guthrie cards, include a control for storage conditions. Cards stored for >10 years may yield degraded DNA; a control of known age helps interpret results [1].

Conceptual Workflow

Step 1: Sample Preparation and Punching

1. Wearing gloves, remove the DBS card from its protective envelope. Inspect for visible contamination, mold, or damage.
2. Using a clean punch, excise 1–6 discs (typically 3 mm diameter) from the center of the blood spot. Avoid the edges where blood may be unevenly distributed.
3. Place discs into a 1.5 mL or 2 mL microcentrifuge tube. If using multiple punches from the same sample, pool them in one tube.

Why this matters: The number of punches determines DNA yield. A single 3 mm punch from a well-saturated spot contains approximately 3 µL of whole blood, yielding 30–100 ng of DNA. For applications requiring >200 ng (e.g., whole genome amplification), use 3–6 punches.

Step 2: Lysis and Digestion

1. Add 180 µL of lysis buffer and 20 µL of proteinase K (20 mg/mL) to the tube containing the punches.
2. Vortex briefly to ensure the discs are submerged.
3. Incubate at 56°C for 1–2 hours with intermittent vortexing (every 20–30 minutes). For archival samples (>5 years old), extend incubation to 4 hours or overnight.

Why this matters: Prolonged digestion improves DNA release from aged samples where crosslinking may have occurred. However, excessive incubation (>16 hours) can lead to DNA shearing.

Step 3: Binding to Solid Phase

1. Add 200 µL of binding buffer (e.g., Buffer AL from Qiagen kits) and 200 µL of 96–100% ethanol. Mix thoroughly by vortexing.
2. Transfer the mixture to a silica membrane column placed in a collection tube.
3. Centrifuge at 6,000 × g for 1 minute. Discard flow-through.

Why this matters: The ethanol concentration must be within the range specified by the kit manufacturer (typically 50–70% final) to ensure efficient DNA binding. Too little ethanol reduces binding; too much can precipitate salts.

Step 4: Washing

1. Add 500 µL of wash buffer 1 (e.g., Buffer AW1). Centrifuge at 6,000 × g for 1 minute. Discard flow-through.
2. Add 500 µL of wash buffer 2 (e.g., Buffer AW2). Centrifuge at 14,000 × g for 3 minutes to dry the membrane.
3. Optional: Perform an additional dry spin for 1 minute to remove residual ethanol.

Why this matters: Thorough washing removes heme, porphyrins, and other inhibitors. Residual ethanol in the eluate can inhibit downstream enzymatic reactions.

Step 5: Elution

1. Transfer the column to a clean microcentrifuge tube.
2. Add 50–100 µL of elution buffer (Buffer AE or nuclease-free water) directly onto the center of the membrane.
3. Incubate at room temperature for 5 minutes, then centrifuge at 6,000 × g for 1 minute.
4. For higher yield, repeat elution with a second aliquot of buffer, or incubate at 70°C for 5 minutes before centrifugation.

Why this matters: Elution volume affects DNA concentration. Use 50 µL for concentrated DNA (suitable for PCR) or 100 µL for higher total yield (suitable for multiple assays). Heating to 70°C improves elution efficiency but may cause slight DNA shearing.

Quality Checks

Quantification

• UV-Vis spectrophotometry (NanoDrop): Measure absorbance at 260 nm (DNA), 280 nm (protein), and 230 nm (organic contaminants). Pure DNA has A260/A280 ratio of 1.8–2.0 and A260/A230 ratio of 2.0–2.2. Lower ratios indicate protein or organic contamination.
• Fluorometry (Qubit): Use a dsDNA-specific assay (e.g., Qubit dsDNA HS or BR) for accurate quantification, especially when DNA concentration is low (<10 ng/µL). Fluorometry is not affected by RNA or free nucleotides.

Integrity Assessment

• Agarose gel electrophoresis: Run 5 µL of extracted DNA on a 1% agarose gel with a DNA ladder. High-molecular-weight DNA appears as a single band >10 kb. Smearing indicates degradation.
• TapeStation or Bioanalyzer: For precise sizing, use microfluidic electrophoresis. A DNA integrity number (DIN) >7 indicates good quality.

Purity for Downstream Applications

• PCR inhibition test: Perform a qPCR targeting a single-copy human gene (e.g., RNase P or β-globin). Compare Ct values of the sample to a dilution series of known DNA. A shift of >2 Ct compared to expected indicates inhibition.
• Spike-in control: Add a known amount of exogenous DNA (e.g., lambda phage DNA) to a replicate PCR reaction. If the spike-in fails to amplify, inhibitors are present.

Result Interpretation

Yield Expectations

• Fresh DBS (stored <1 year): 50–150 ng per 3 mm punch
• Archival Guthrie cards (5–20 years old): 10–80 ng per 3 mm punch
• Polymeric DBS devices: 100–300 ng per 20 µL spot

Quality Assessment

Downstream Compatibility

• Conventional PCR: Works with 10–100 ng DNA per 25 µL reaction
• qPCR: Works with 5–50 ng DNA per 20 µL reaction
• Nested PCR: Useful for low-copy-number targets; requires 10–50 ng DNA [1]
• Sequencing: Requires 50–200 ng DNA for library preparation; degraded DNA (<500 bp fragments) may limit performance

Troubleshooting

Limitations

Sample-Related Limitations

• Blood volume variability: DBS spots may have uneven blood distribution, leading to variable DNA yield between punches. Always punch from the center of the spot where blood is most concentrated.
• Sample age: DNA from archival Guthrie cards (>10 years old) is often degraded (average fragment size 200–500 bp) and may not support long-range PCR or whole genome amplification [1].
• Hematocrit effects: Individuals with high hematocrit (>50%) produce smaller spots with more concentrated blood, while anemic individuals produce larger, more dilute spots. This affects DNA yield per punch.

Technical Limitations

• Inhibitor carryover: Heme and porphyrins are difficult to remove completely from cellulosic paper. Polymeric devices reduce but do not eliminate this issue [3].
• Lower sensitivity compared to fresh blood: DBS-based detection of viral DNA is 10–30 fold less sensitive than fresh blood due to smaller sample volume and partial DNA degradation [3][4].
• Cross-contamination risk: Automated punchers can carry over DNA between samples if not properly cleaned. Manual punching with disposable tips reduces this risk.

Application-Specific Limitations

• Quantitative PCR: DBS DNA may overestimate viral load due to the presence of cellular nucleic acids from leukocytes. Plasma separation cards (PSC) improve specificity by removing cellular components [4].
• Epigenetic analysis: DNA methylation patterns can be altered during the drying and storage process. Validation against fresh blood is recommended [2].
• Whole genome sequencing: Requires >1 µg of high-molecular-weight DNA, which is difficult to obtain from DBS. Multiple punches (10–20) may be needed.

Documentation

Essential Records

1. Sample metadata: Collection date, device type, storage conditions (temperature, humidity), sample age
2. Extraction log: Date, technician, kit lot number, number of punches, lysis time, elution volume
3. Quality control data: Quantification results (NanoDrop and Qubit), gel image, A260/A280 and A260/A230 ratios
4. PCR results: Ct values, inhibition control results, positive/negative control outcomes

Recommended Documentation Format

Maintain a laboratory notebook or electronic lab notebook (ELN) with the following sections:

• Sample receipt: Record condition of DBS cards upon arrival (intact, damaged, contaminated)
• Extraction protocol: Note any deviations from the standard protocol (e.g., extended digestion, modified wash steps)
• Quality metrics: Tabulate quantification results for each sample batch
• Troubleshooting notes: Document any issues encountered and corrective actions taken

Chain of Custody

For clinical or forensic applications, maintain a chain of custody form that tracks:

• Sample collection (who, when, where)
• Sample transport (courier, temperature monitoring)
• Sample storage (location, access log)
• Sample processing (technician, date, protocol version)

Biosafety Considerations

Risk Assessment

Dried blood spots are considered BSL-1 materials when collected from healthy donors in a research setting. However, all human blood products should be treated as potentially infectious for bloodborne pathogens (HIV, HBV, HCV). The CDC and NIH BMBL 6th Edition recommends universal precautions for handling all human blood specimens [6].

Safe Work Practices

1. Personal protective equipment (PPE): Wear lab coat, gloves, and safety glasses when handling DBS cards and extraction reagents.
2. Work area: Perform extraction in a designated area separate from PCR setup to prevent contamination.
3. Sharps disposal: Discard used punches and needles in a puncture-resistant sharps container.
4. Decontamination: Clean work surfaces with 10% bleach or 70% ethanol after each session.
5. Waste disposal: Dispose of DBS cards and extraction waste as biohazardous waste according to institutional guidelines.

Recombinant DNA Considerations

If the extracted DNA will be used for PCR amplification of recombinant or synthetic nucleic acid molecules, follow the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules [7]. Most DBS-based PCR studies fall under exempt or BSL-1 containment, but institutional biosafety committee (IBC) approval may be required.

Special Considerations for Archival Samples

Guthrie cards from newborn screening programs may contain residual blood from infants whose infectious status is unknown. Treat all archival cards as potentially infectious. Some cards may have been stored for decades; inspect for visible mold or bacterial growth before processing.

Frequently Asked Questions

Q1: Can I use DBS-extracted DNA for whole genome sequencing?

DBS-extracted DNA is generally not suitable for whole genome sequencing due to limited yield (typically <1 µg from 10 punches) and degradation (average fragment size 200–500 bp for archival samples). For fresh DBS, you may obtain sufficient DNA for targeted sequencing or exome capture, but whole genome sequencing requires >1 µg of high-molecular-weight DNA. Consider using multiple punches (15–20) and a high-yield extraction method (e.g., phenol-chloroform) if sequencing is required.

Q2: How long can DBS cards be stored before DNA extraction?

DNA in dried blood spots is remarkably stable. Studies have successfully extracted amplifiable DNA from Guthrie cards stored for >20 years at room temperature [1]. For optimal results, store cards in a low-humidity environment (<30% relative humidity) away from direct sunlight. DNA yield decreases approximately 10–20% per decade of storage. For long-term storage (>5 years), consider storing cards in sealed plastic bags with desiccant.

Q3: What is the difference between DBS and plasma separation cards (PSC) for viral DNA detection?

DBS contain all blood components, including cellular nucleic acids from leukocytes. This can lead to overestimation of viral load because cellular DNA may contain integrated viral sequences or non-specific amplification products. Plasma separation cards (PSC) use a membrane that retains cellular components while allowing plasma to pass through, yielding a sample free of cellular nucleic acids. PSC show improved specificity for viral load monitoring but require a larger blood volume (100–200 µL) compared to DBS (20–50 µL) [4].

Q4: Can I use DBS-extracted DNA for methylation analysis?

Yes, but with caveats. DNA methylation patterns can be altered during the drying and storage process due to oxidative damage or enzymatic activity. A study on occupational exposure monitoring found that global DNA methylation could be measured from DBS, but the results should be validated against fresh blood samples from the same individuals [2]. For best results, extract DNA within 1 week of collection and store eluted DNA at -80°C. Avoid repeated freeze-thaw cycles.

References and Further Reading

1. Detection of Adenoviral E1A Gene in Guthrie Cards for Insights into Pediatric Cancer Origin – Mendoza G, Guerrero R, Strunk M, et al. (2026). Demonstrates optimized DNA extraction from archival Guthrie cards for viral DNA detection using nested PCR.

2. Dried blood spot-based monitoring of immune and epigenetic biomarkers in occupational exposure studies – De Ryck E, Hoornaert EM, Buntinx Y, et al. (2026). Validates DBS DNA extraction for global DNA methylation and immune marker analysis.

3. Improvement of EPO Transgene Detection From Polymeric Dried Blood Spots for Antidoping Application – Marchand A, Roulland I, Ericsson M. (2026). Compares cellulosic and polymeric DBS devices for DNA extraction sensitivity.

4. Dried Blood Spots and Plasma Separation Cards can Broaden Access to Molecular Testing for HBV, HCV and HIV – Lazarus JV, Parkin N, Qureshi H, et al. (2025). Reviews DBS and PSC performance for viral nucleic acid testing.

5. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition – CDC and NIH (2020). Authoritative biosafety guidelines for handling human blood products.

6. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules – National Institutes of Health. Regulatory framework for recombinant DNA research.

7. NCBI Bookshelf: Molecular Biology and Laboratory Methods – National Center for Biotechnology Information. Searchable collection of molecular biology protocols and methods.

8. Diagnostic accuracy of self-collected menstrual blood for high-risk human papillomavirus testing – Ji X, Ji X, Chen S, et al. (2026). Provides context for self-collected blood spot methods in HPV detection.

Related Articles

• Genomic DNA Extraction from Blood: Protocols and Quality Assessment
• Gel Extraction of DNA: Purification from Agarose Gels
• DNA Extraction from Soil: Protocols for Environmental Samples
• DNA Extraction from Bacteria Using Boiling Method: Quick Protocol
• RNA Extraction from Blood: Protocols for Total RNA from Whole Blood
• DNA Extraction from Water Samples: Methods for Environmental DNA